To: Cautious_Optimist who wrote (2170 ) 7/14/1999 11:48:00 PM From: Mike M Read Replies (1) | Respond to of 10293
However it appears to me that Bill Wexler's insights have generally proven quite insightful and well-researched. In general John, I suspect you may be right and I appreciate your comments. Otherwise why would you guys congregate around here. I am a military man so my analogy sticks to knitting. Napoleon was a great general but ran into trouble at Waterloo. McArthur also a great general ran into trouble at the Yalu River...The generals began to believe their "press agents" and failed to take proper counsel. Their problems, underestimating the enemy and not listening to reason got them into plenty of trouble. In the case of GUMM he (admittedly) didn't give it enough DD and I think he pays for that. The company isn't perfect, no company is...but it is hardly the short sale candidate he claims it to be. Sometimes being right too often can get you into trouble. Harmond convinced him that Yahoo! was a buy rather than a short so I know he has the ability to listen... Along with Howard & Dan, I have two years of due diligence and w/ thirty years of investment experience, I thought I could offer some cogent reasons that this stock was a bad short candidate. Instead I was immediately greeted as a shill with an axe to grind. John, I have watched Gary Kehoe pick this company up from a near death experience and I think after 30 years I know a survivor when I see one....Funny thing is, I don't really care at this point whether the stock is shorted or not....major shorting has accomplished nothing but allow the stock to grow from 4 to 13 in the last year or so...I was intrigued by the claim that the stock wasn't worth a buck a share so came to hear what he had to say...Had Bill shown me something I didn't know, I would have been grateful...Not the case. this effort was from the hip and was a cursory financial analysis... Nobody needed to tell me that. Hasn't been that long since the company sent its former CEO packing and stopped burning cash by changing market strategy. But things have changed and I could see that that was not common knowledge at the dog pound. I don't know if NEJM will publish the Zicam article or not. Regardless, the cold medicine will survive and thrive because it works and because Gary knows distribution. But, if it does get published, if we have learned anything from VPHM, the market will respond to a cold remedy that works...and it will do so violently. One final observation, John...the definition of a "shill" is not someone who disagrees with Bill. Regards, Mike